- Home
- AUTL vs VREX Comparison
AUTL vs VREX Comparison
Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- VREX
- Stock Information
- Founded
- AUTL 2014
- VREX 2016
- Country
- AUTL United Kingdom
- VREX United States
- Employees
- AUTL N/A
- VREX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- VREX Industrial Machinery/Components
- Sector
- AUTL Health Care
- VREX Technology
- Exchange
- AUTL Nasdaq
- VREX Nasdaq
- Market Cap
- AUTL 625.4M
- VREX 343.3M
- IPO Year
- AUTL 2018
- VREX N/A
- Fundamental
- Price
- AUTL $2.47
- VREX $8.19
- Analyst Decision
- AUTL Strong Buy
- VREX Strong Buy
- Analyst Count
- AUTL 5
- VREX 2
- Target Price
- AUTL $9.32
- VREX $22.50
- AVG Volume (30 Days)
- AUTL 1.8M
- VREX 395.3K
- Earning Date
- AUTL 08-07-2025
- VREX 07-31-2025
- Dividend Yield
- AUTL N/A
- VREX N/A
- EPS Growth
- AUTL N/A
- VREX N/A
- EPS
- AUTL N/A
- VREX N/A
- Revenue
- AUTL $9,011,000.00
- VREX $827,500,000.00
- Revenue This Year
- AUTL $461.76
- VREX $0.73
- Revenue Next Year
- AUTL $112.66
- VREX $4.40
- P/E Ratio
- AUTL N/A
- VREX N/A
- Revenue Growth
- AUTL N/A
- VREX N/A
- 52 Week Low
- AUTL $1.11
- VREX $6.76
- 52 Week High
- AUTL $5.00
- VREX $16.93
- Technical
- Relative Strength Index (RSI)
- AUTL 69.22
- VREX 52.63
- Support Level
- AUTL $2.24
- VREX $8.28
- Resistance Level
- AUTL $2.53
- VREX $8.83
- Average True Range (ATR)
- AUTL 0.13
- VREX 0.36
- MACD
- AUTL -0.00
- VREX 0.01
- Stochastic Oscillator
- AUTL 88.55
- VREX 66.19
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.